AI21 Labs stock
Private-market facts for current and former AI21 Labs employees researching their stock.
Overview
AI21 Labs builds enterprise-grade large language models including the Jamba family, offering an AI platform that helps businesses deploy generative AI for text generation, summarization, and comprehension tasks.
AI21 Labs outlook
For employees evaluating AI21 Labs equity, a 1x base multiple suggests the stock may be close to fairly valued at current prices. The upside scenario at 2x is relatively close to the base case, suggesting more predictable but narrower range of outcomes.
These estimates reflect modeled return scenarios, not guaranteed outcomes. Actual results depend on company performance, market conditions, share class, and timing.
Selling AI21 Labs shares
Why shareholders consider selling
Shareholders in AI21 Labs may explore liquidity for a number of reasons — diversifying a concentrated position, funding a personal financial goal, or simply reducing exposure to a single private holding. As a private company, AI21 Labs does not trade on a public exchange, meaning employees and early shareholders cannot simply sell through a brokerage. Extended private timelines can leave shareholders waiting years for an exit event, which is why some choose to explore secondary-market options.
Can you sell AI21 Labs stock?
Whether a shareholder can sell typically depends on what they hold and how it was acquired. Vested and exercised shares are generally more straightforward than unexercised options or unvested RSUs. Most private companies, including those in the Artificial Intelligence sector, impose transfer restrictions such as rights of first refusal or board approval requirements. The specific terms governing AI21 Labs shares would be outlined in the holder's equity agreement or the company's governing documents.
What affects the value of AI21 Labs shares?
The price a buyer is willing to pay for private shares is shaped by several factors: overall demand for the stock, the company's financial performance, broader Artificial Intelligence market conditions, and any recent private-market transaction activity. Data points such as the company's Series D round and its reported $3B valuation can help frame expectations, though they do not guarantee a transaction price.
What should holders check before selling
- The type of security held (common shares, preferred, options, RSUs)
- Whether the equity is fully vested and, for options, whether it has been exercised
- Any transfer restrictions, lock-up provisions, or company approval requirements
- Estimated net proceeds after applicable taxes and transaction fees
- Whether partial liquidity — selling a portion rather than the full position — may be a better fit
Tools for AI21 Labs shareholders
Exploring equity in AI21 Labs often raises questions about taxes, exercise timing, valuation, and exit outcomes. These tools can help you model different decisions using your own assumptions.
Latest funding round
AI21 Labs most recently raised a Series D round . The company was valued at $3B. Total funding raised to date is approximately $336M.
Lead investors in this round include Nvidia and Intel Capital.
Founders & company background
AI21 Labs was founded in 2017 by Yoav Shoham, Ori Goshen, Amnon Shashua and is headquartered in Tel Aviv, Israel.
Investors
Industry
Similar private companies
Latest AI21 Labs news
Frequently asked questions
- Is AI21 Labs still a private company?
- Yes, AI21 Labs is currently a private company.
- What is AI21 Labs's latest funding round?
- AI21 Labs's most recent known round is Series D.
- What is AI21 Labs's valuation?
- AI21 Labs's latest reported valuation is $3B.
- Who are the investors in AI21 Labs?
- Notable investors include Nvidia, Intel Capital, Google, Walden Catalyst, Pitango Venture Capital.
- Can I sell my AI21 Labs stock?
- Private company shares can sometimes be sold on secondary markets. Speaking with a specialist who understands AI21 Labs stock can help you evaluate your options.
Related pages
Last verified: 2026-04-13 · AI21 Labs data compiled from funding disclosures, investor announcements, corporate filings, and public records.
Information on this page is compiled from publicly available sources and may be outdated or incomplete. This is not investment advice. Consult a qualified advisor before making financial decisions.